Collection Kits Market Size, Share Global Analysis Report, 2026-2034

Industry Insights

[232+ Pages Report] According to Facts & Factors, the global Collection Kits market size was estimated at USD 4.96 billion in 2025 and is expected to reach USD 11.28 billion by the end of 2034. The Collection Kits industry is anticipated to grow by a CAGR of 9.6% between 2026 and 2034. The Collection Kits Market is driven by surging demand for infectious disease testing, rapid expansion of at-home & direct-to-consumer diagnostics, increasing genetic & oncology screening programs, and continuous innovation in non-invasive specimen collection technologies.

Market Overview

The Collection Kits market encompasses specialized, ready-to-use medical devices and consumable sets designed for safe, standardized, and contamination-free collection, stabilization, transport, and short-term storage of biological specimens from patients for downstream diagnostic testing, genetic analysis, or research. These kits typically include swabs or collection tubes, transport/stabilization media, barcoded labels, instructions, and return packaging, formulated to maintain specimen integrity during transit to laboratories. The market serves clinical diagnostics, at-home/self-collection testing, clinical trials, population screening programs, and research applications, balancing regulatory compliance, user-friendliness, and cost-effectiveness across professional and consumer channels.

Key Insights

• As per the analysis shared by our research analyst, the Collection Kits market is estimated to grow annually at a CAGR of around 9.6% over the forecast period (2026-2034).
• In terms of revenue, the Collection Kits market size was valued at around USD 4.96 billion in 2025 and is projected to reach USD 11.28 billion by 2034.
• The Collection Kits Market is driven by persistent infectious disease burden, explosive growth in direct-to-consumer & at-home testing, and rising genetic & oncology screening programs.
• Based on the Type, the Swab Collection Kits segment dominated the market in 2025 with a share of 52% due to universal use in respiratory pathogen testing, COVID-19 legacy demand, and broad applicability across infectious disease, genetic, and oncology panels.
• Based on the Application, the Infectious Disease Testing segment dominated the market in 2025 with a share of 58% owing to ongoing demand for respiratory virus, STI, and emerging pathogen panels, together with large-scale public health screening programs.
• Based on the End-User, the Diagnostic Laboratories segment dominated the market in 2025 with a share of 44% because centralized high-throughput labs process the majority of collected specimens and drive bulk procurement of standardized kits.
• Asia Pacific dominated the global Collection Kits market in 2025 with a share of 42%, attributed to a massive population, the highest infectious disease testing volumes, the fastest growth in private diagnostics, and the rapid expansion of at-home testing in China and India.

Growth Drivers

• Infectious Disease & Pandemic Preparedness Demand

Persistent circulation of respiratory viruses, rising STI rates, and preparedness for future outbreaks sustain high-volume swab-based collection kit consumption in clinical and public health settings.

Expansion of multiplex molecular panels, antigen rapid tests, and self-collection programs for infectious diseases drives consistent demand for viral transport media and swab kits across hospitals, labs, pharmacies, and direct-to-consumer channels.

Restraints

• Reimbursement & Pricing Pressure

In many healthcare systems, reimbursement for specimen collection kits remains bundled or limited, especially for at-home and non-invasive methods, constraining growth in consumer and low-margin segments.

Intense competition among manufacturers, overcapacity in swab and transport media production post-COVID, and downward pricing pressure from large lab buyers limit profitability in commoditized infectious disease collection kits.

Opportunities

• At-Home & Direct-to-Consumer Testing Expansion

Rapid growth of DTC genetic testing, at-home microbiome, hormone, and chronic disease monitoring kits creates a high-margin opportunity for user-friendly, mail-in collection kits with stabilization media.

Integration of collection kits with telehealth platforms, mobile phlebotomy services, and decentralized clinical trials opens new channels for blood, saliva, and urine kits in remote and underserved populations.

Challenges

• Supply Chain & Raw Material Risks

Dependence on specific plastics, flocked swabs, transport media preservatives, and sterilization capacity creates vulnerability to shortages, price spikes, and quality issues, as seen during pandemic peaks.

Stringent regulatory requirements for collection devices, especially for infectious disease and genetic testing, increase validation timelines and costs, particularly for novel stabilization chemistries.

Report Scope

Market Segmentation

The Collection Kits market is segmented by type, application, end-user, and region.

Based on Type Segment, the Collection Kits market is divided into swab collection kits, saliva collection kits, blood collection kits, urine collection kits, stool collection kits, and others. The most dominant segment is Swab Collection Kits, followed by Saliva Collection Kits. Swab Collection Kits dominate because they remain the gold standard for respiratory pathogen detection, STI testing, and large-scale infectious disease screening, offering high sensitivity in PCR and antigen formats, widespread clinical acceptance, and continued high-volume use in hospitals, public health labs, and DTC channels worldwide.

Based on Application Segment, the Collection Kits market is divided into infectious disease testing, genetic testing, oncology testing, drug testing, and others. The most dominant segment is Infectious Disease Testing, followed by Genetic Testing. Infectious Disease Testing leads due to enormous ongoing testing volumes for respiratory viruses, STIs, emerging pathogens, and public health surveillance, creating the greatest and most consistent demand for swab and saliva collection kits across clinical, point-of-care, and at-home settings globally.

Based on End-User Segment, the Collection Kits market is divided into hospitals & clinics, diagnostic laboratories, home care settings, research institutes, and others. The most dominant segment is Diagnostic Laboratories, followed by Hospitals & Clinics. Diagnostic Laboratories dominate because they process the overwhelming majority of collected specimens, maintain centralized procurement of standardized kits, and drive bulk and recurring orders for both clinical and research applications worldwide.

Recent Developments

• In April 2026, BD launched a new mid-turbinate swab collection kit with improved user comfort and higher viral load recovery for respiratory multiplex panels.
• In February 2026, OraSure Technologies received FDA 510(k) clearance for its next-generation saliva collection device optimized for high-sensitivity HPV and STI molecular testing.
• In December 2025, Thermo Fisher Scientific expanded its Applied Biosystems TaqPath PCR kits with compatible at-home saliva collection tubes featuring new stabilization chemistry for ambient shipping.
• In October 2025, Everlywell introduced a combined blood + saliva self-collection kit for comprehensive hormone, thyroid, and vitamin panel testing with overnight return packaging.
• In July 2025, Cardinal Health partnered with a major lab network to distribute a new stool-based microbiome collection kit with an ambient-stable preservative for DTC gut health testing.

Regional Analysis

• Asia Pacific to dominate the global market

Asia Pacific leads the Collection Kits market through the world’s largest population, highest infectious disease testing volumes, fastest growth in private diagnostics and DTC testing, and rapid expansion of centralized high-throughput labs in China, India, Japan, and South Korea. The region benefits from low-cost local manufacturing of swabs and tubes, aggressive government screening programs, and increasing consumer willingness to pay for at-home genetic and wellness testing. China dominates within Asia Pacific owing to its enormous population, the highest absolute number of diagnostic tests performed annually, massive domestic production capacity for collection kits, widespread use in national infectious disease surveillance, and a rapidly growing DTC and telehealth testing ecosystem.

North America maintains a significant and innovation-driven position in the Collection Kits market, supported by high per-capita diagnostic testing, leadership in DTC genetic and wellness kits, strong reimbursement for infectious disease and oncology panels, and advanced lab infrastructure. The United States dominates within North America due to its massive clinical lab market, highest adoption of at-home self-collection kits, leadership in molecular and genetic testing innovation, and strong presence of major kit manufacturers and DTC brands.

Europe holds steady growth in the Collection Kits market, driven by centralized lab networks, strong public health screening programs, increasing DTC genetic testing, and high regulatory standards for collection devices. Germany dominates within Europe through its advanced diagnostic laboratory sector, leadership in quality and IVD-certified collection kits, centralized procurement by large lab chains, and significant R&D in non-invasive specimen collection technologies.

Latin America shows accelerating growth in the Collection Kits market, fueled by rising infectious disease testing, expanding private lab networks, increasing DTC access in urban areas, and growing public health screening initiatives. Brazil dominates the region with its large population, high prevalence of tropical and respiratory diseases, growing private diagnostics sector, and increasing adoption of saliva and swab kits for both clinical and wellness testing.

The Middle East & Africa region demonstrates emerging potential in the Collection Kits market, supported by rising healthcare investment, increasing infectious disease surveillance, growing private lab infrastructure, and expanding DTC testing in affluent Gulf countries. The United Arab Emirates leads within the region through its world-class healthcare facilities, high demand for premium genetic and wellness testing, strategic focus on diagnostic innovation, and role as a regional hub for imported and locally distributed collection kits.

Competitive Analysis

The global Collection Kits market is dominated by players:

• Becton Dickinson
• Thermo Fisher Scientific
• OraSure Technologies
• QIAGEN
• Copan Diagnostics
• Hardy Diagnostics
• Puritan Medical Products
• Cardinal Health
• Lucira Health
• Everlywell

The global Collection Kits market is segmented as follows:

By Type

• Swab Collection Kits
• Saliva Collection Kits
• Blood Collection Kits
• Urine Collection Kits
• Stool Collection Kits
• Others

By Application

• Infectious Disease Testing
• Genetic Testing
• Oncology Testing
• Drug Testing
• Others

By End-User

• Hospitals & Clinics
• Diagnostic Laboratories
• Home Care Settings
• Research Institutes
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America